Congratulations #TeamSAMBAI who have been awarded $25m to work across 15 institutions in 3 continents to tackle #cancerdisparities in populations of African ancestry! We are honoured to join forces with this amazing team and contribute to research against such an important cause.
The secret is out! I am absolutely thrilled to announce my participation in TEAM SAMBAI, led by the amazing @MeliD32. Together, we are embarking on a mission to make significant strides in addressing cancer inequalities on a global scale.
We had an incredible launch 🚀of our #SAMBAI PPI event @KingsCollegeLon! Talks by @rickidove, @DrKeertiGedela & patient advocates highlighted the power of inclusion, patient voices🗣️, and bridging research with those it impacts most. Representation drives better #CancerResearch !
🚨 Tune in for EP5 of SAMBAI Speaks 🗣️- highlighting WP4 from @CancerGrand Team SAMBAI tackling global cancer disparities. WP4: Tumor Biology & Immune Profiling ft Dr Nigel Mongan, Dr. Clayton Yates, Dr. Sheeba Irshad & Patient Advocate Alfred Samuels. 6pm GMT/ 1pm ET
During her visit to @kingsmedicine we showcased our biobanking and clinical translation workflows. Key discussions on translational cancer research and the innovative #BIAALCL project with @royalmarsdenNHS highlighted the consortium's innovative potential in Poland and beyond! 🚀
Exciting start to the #P4Health project! 🎉 We were delighted to host Dr. Patrycja Gazinska, Biobank Group Lead at @PORT_Wroclaw for the launch of our #HorizonEU collaboration. Her leadership in molecular and computational pathology at PORT sets the stage for groundbreaking work.
Countdown to the first patient summit of its kind, the @Make2ndsCount secondary breast cancer conference starting tomorrow. Looking forward to learning lots from experts by experience and experts by profession including @cancermedic@FallowfieldLJ#BreastCancer#patientvoice
Today we celebrated the vital work our researchers are doing with a visit to our research unit at @KingsCollegeLon, which is focused on studying triple negative breast cancer.
Thank you to all who attended and to King's College London for hosting us.
A great session on Immune-Monitoring in Haematology; Lessons from solid tumours. Excellent talks by Sheeba Irshad and Jonathan Irish. 👌👌
#EHA2024@SheebaIrshad@jonathanirish
Our latest paper in JAMA Surgery: Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women. We uncovered a bias in survival benefits of TAL leading into forthcoming work on ancestry-associated tumor immunology. Stay tuned!
https://t.co/ZmIAg7dHHZ
Scientists at King's have been chosen by @CancerGrand to receive up to $25m over 5 years to take on two of cancer’s toughest challenges.
The teams PROSPECT and SAMBAI will advance progress in early-onset cancers and cancer inequities.
Find out more ⬇️
https://t.co/bESdGCq17z
.@SheebaIrshad from Team SAMBAI will establish a groundbreaking resource focused on breast, prostate and pancreatic cancer in individuals of African descent to improve cancer outcomes for ethnic minorities.
Read more @itvnews ⬇️ #CancerGrandChallenges
https://t.co/tTfJUldeag
Very excited to be part of team SAMBAI. This represents the largest single NCI/CRUK award for cancer inequities ever. For @YemaachiBio to be one of 2 African partners (and the only biotech) responsible for centering large part of this work in Africa is both humbling and exciting.
I am delighted to share that @CancerGrand Challenges have announced funding for 5 new teams - KOODAC, MATCHMAKERS, PROSPECT, PROTECT, and SAMBAI. They’ll be tackling some of the biggest questions in cancer research.
Read more on their projects here 👇